Form4insider filings, from the source

SEC Form 4 · accession 0001628280-26-048832

Ginkgo Bioworks Holdings, Inc. · DNA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Steven P. Coen
Officer — See remarks
Period of report
Jul 16, 2026
Accepted (ET)
Jul 20, 2026 · 5:00 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001830214

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Class A Common StockF1Jul 16, 2026M1,174—A51,878D
Class A Common StockF1Jul 16, 2026M312—A52,190D
Class A Common StockJul 17, 2026S752$7.903D51,438D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF1,F3—Jul 16, 2026M1,174D——Class A Common Stock1,1745,883D
Restricted Stock UnitsF1,F4—Jul 16, 2026M312D——Class A Common Stock3123,131D

Explanation of responses

Remarks

Chief Financial Officer